Nuvasive Inc's Revenue in the fiscal year 2022 $ 1,201.94 millions
Nuvasive Inc's Revenue in the fiscal year 2021 $ 1,138.99 millions
Nuvasive Inc's Revenue in the fiscal year 2020 $ 1,050.58 millions
Nuvasive Inc's Revenue in the fiscal year 2019 $ 1,168.07 millions
Nuvasive Inc's Revenue in the fiscal year 2018 $ 1,101.71 millions
NUVA Revenue second quarter 2023 Y/Y Growth Comment
Nuvasive Inc reported Revenue growth of 2.36% year on year in the second quarter 2023, to $ 317.79 millions, this is lower than Nuvasive Inc's recent average Revenue growth of 6.97%.
Looking into second quarter 2023 results within Medical Equipment & Supplies industry 135 other companies have achieved higher Revenue growth. While Nuvasive Inc' s Revenue increase of 2.36% ranks overall at the positon no. 2351 in the second quarter 2023.
Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023
Nuvasive Inc's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
45.02 %
0.45 %
-100 %
(Sep 30 2020)
NUVA's II. Quarter Q/Q Revenue Comment
Nuvasive Inc achieved in the II. Quarter 2023 above company average sequential Revenue growth of 3.27%, to $ 317.79 millions, from $307.71 millions in the first quarter.
Within Medical Equipment & Supplies industry 124 other companies have achieved higher Revenue quarter on quarter growth. While Nuvasive Inc's Revenue growth quarter on quarter, overall rank is 2108.
Nuvasive Inc achieved in the II. Quarter 2023 above company average sequential Revenue growth of 3.27%, to $ 317.79 millions, from $307.71 millions in the first quarter.
Within Medical Equipment & Supplies industry 124 other companies have achieved higher Revenue quarter on quarter growth. While Nuvasive Inc's Revenue growth quarter on quarter, overall rank is 2108.
Nuvasive Inc's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2023)
12 Months Ending (Mar 31 2023)
12 Months Ending (Dec 31 2022)
12 Months Ending (Sep 30 2022)
12 Months Ending (Jun 30 2022)
Cumulative Revenue 12 Months Ending
$ 1,226.23
$ 1,218.89
$ 1,201.94
$ 1,198.57
$ 1,174.12
Y / Y Revenue Growth (TTM)
4.44 %
5.21 %
5.53 %
6.19 %
1.82 %
Year on Year Revenue Growth Overall
Ranking
# 2438
# 1231
# 1370
# 1962
# 851
Seqeuential Revenue Change (TTM)
0.6 %
1.41 %
0.28 %
2.08 %
1.35 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2469
# 2426
# 2596
# 1896
# 1725
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2023 period, Nuvasive Inc's cumulative twelve months Revenue were $ 1,226 millions, company would post below average annual Revenue growth of 1.35% year on year, if the fiscal year would end at Jun 30 2023. A slow-down in the Nuvasive Inc's Revenue growth from the 307.71% growth in Mar 31 2023.
In the Healthcare sector 362 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1231 to 2438.
With the quarterly Revenue reported in the Jun 30 2023 period, Nuvasive Inc's cumulative twelve months Revenue were $ 1,226 millions, company would post below average annual Revenue growth of -10.06% year on year, if the fiscal year would end at Jun 30 2023. A slow-down in the Nuvasive Inc's Revenue growth from the 307.71% growth in Mar 31 2023.
In the Healthcare sector 362 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1231 to 2438.
About Nuvasive Inc Revenue Growth Rates (NUVA), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
3.89%